These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38191420)

  • 1. Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies.
    Theobald V; Schmitt FCF; Middel CS; Gaissmaier L; Brenner T; Weigand MA
    Crit Care; 2024 Jan; 28(1):17. PubMed ID: 38191420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM-1 Modulation Strategies for Sepsis.
    Siskind S; Brenner M; Wang P
    Front Immunol; 2022; 13():907387. PubMed ID: 35784361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
    François B; Lambden S; Fivez T; Gibot S; Derive M; Grouin JM; Salcedo-Magguilli M; Lemarié J; De Schryver N; Jalkanen V; Hicheur T; Garaud JJ; Cuvier V; Ferrer R; Bestle M; Pettilä V; Mira JP; Bouisse C; Mercier E; Vermassen J; Huberlant V; Vinatier I; Anguel N; Levy M; Laterre PF;
    Lancet Respir Med; 2023 Oct; 11(10):894-904. PubMed ID: 37269870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes- induced sepsis.
    Horst SA; Linnér A; Beineke A; Lehne S; Höltje C; Hecht A; Norrby-Teglund A; Medina E; Goldmann O
    J Innate Immun; 2013; 5(6):581-90. PubMed ID: 23571837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock.
    Jolly L; Carrasco K; Derive M; Lemarié J; Boufenzer A; Gibot S
    Cardiovasc Res; 2018 May; 114(6):907-918. PubMed ID: 29361046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of the diagnostic value of TREM-1 as marker for fatal sepsis cases.
    Maiese A; Bolino G; Mastracchio A; Frati P; Fineschi V
    Biotech Histochem; 2019 Apr; 94(3):159-166. PubMed ID: 30388897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.
    Sigalov AB
    Int Immunopharmacol; 2014 Jul; 21(1):208-19. PubMed ID: 24836682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis.
    Shi X; Zhang Y; Wang H; Zeng S
    Med Sci Monit; 2017 Oct; 23():5049-5055. PubMed ID: 29059148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
    Liu CJ; Tsai CY; Chiang SH; Tang SJ; Chen NJ; Mak TW; Sun GH; Sun KH
    J Autoimmun; 2017 Mar; 78():92-100. PubMed ID: 28089248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial.
    Francois B; Lambden S; Gibot S; Derive M; Olivier A; Cuvier V; Witte S; Grouin JM; Garaud JJ; Salcedo-Magguilli M; Levy M; Laterre PF
    BMJ Open; 2021 Jul; 11(7):e042921. PubMed ID: 34233965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review.
    Dantas PHDS; Matos AO; da Silva Filho E; Silva-Sales M; Sales-Campos H
    Int Rev Immunol; 2020; 39(4):188-202. PubMed ID: 32379561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies.
    de Oliveira YLM; de Sá Resende A; Martins-Filho PR; de Moura TR
    Inflammopharmacology; 2022 Jun; 30(3):1037-1045. PubMed ID: 35347523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.
    Cao C; Gu J; Zhang J
    Front Med; 2017 Jun; 11(2):169-177. PubMed ID: 28425045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering receptor expressed on myeloid cells-1 (TREM-1) inhibition in atherosclerosis.
    Panagopoulos A; Samant S; Bakhos JJ; Liu M; Khan B; Makadia J; Muhammad F; Kievit FM; Agrawal DK; Chatzizisis YS
    Pharmacol Ther; 2022 Oct; 238():108182. PubMed ID: 35390422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Purification of a Functional Porcine Soluble Triggering Receptor Expressed on Myeloid Cells 1.
    Li H; Guo S; Yan L; Meng C; Hu Y; He K; Shi Z
    Anim Biotechnol; 2017 Oct; 28(4):237-241. PubMed ID: 28631997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation.
    Gibot S; Jolly L; Lemarié J; Carrasco K; Derive M; Boufenzer A
    Front Immunol; 2019; 10():2314. PubMed ID: 31632399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of triggering receptors expressed by myeloid cells-1 in macrophages stimulated by Porphyromonas gingivalis-lipopolysaccharide].
    Yang Y; Chen SS; Xu CM; Wu YF; Zhao L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):475-481. PubMed ID: 30465338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface TREM-1 as a Prognostic Biomarker in Pediatric Sepsis.
    Şen S; Kamit F; İşgüder R; Yazıcı P; Bal ZŞ; Devrim İ; Bayram SN; Karapınar B; Anıl AB; Vardar F
    Indian J Pediatr; 2021 Feb; 88(2):134-140. PubMed ID: 32572693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis.
    Gibot S; Massin F; Le Renard P; Béné MC; Faure GC; Bollaert PE; Levy B
    Crit Care Med; 2005 Aug; 33(8):1787-93. PubMed ID: 16096457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS.
    Oku R; Oda S; Nakada TA; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Tateishi Y; Ito M; Iseki T; Hirasawa H
    Cytokine; 2013 Jan; 61(1):112-7. PubMed ID: 23046618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.